Antibody-Dependent NK Cell Activation Differentially Targets EBV-Infected Cells in Lytic Cycle and Bystander B Lymphocytes Bound to Viral Antigen-Containing Particles

• Published in: The Journal of immunology (1950) 2017-07, Vol.199 (2), p.656-665
• Main Authors: López-Montañés, María, Alari-Pahissa, Elisenda, Sintes, Jordi, Martínez-Rodríguez, José E, Muntasell, Aura, López-Botet, Miguel
• Format: Article
• Language: English
• Subjects: Antibody-Dependent Cell Cytotoxicity; Antibody-dependent cell-mediated cytotoxicity; B-Lymphocytes - immunology; CD16 antigen; CD20 antigen; Cell activation; Cell Line, Tumor; Cell lines; Cytotoxicity; Degranulation; Herpesvirus 4, Human - immunology; Humans; Infections; Interferon; Interferon-gamma - immunology; Interferon-gamma - secretion; Killer Cells, Natural - immunology; Killer Cells, Natural - physiology; Lymphocyte Activation; Lymphocyte receptors; Lymphocytes; Lymphocytes B; Monoclonal antibodies; Natural killer cells; Rituximab; T cell receptors; Tumor Necrosis Factor-alpha - immunology; Tumor Necrosis Factor-alpha - secretion; Tumor necrosis factor-α; Viral infections; Virion - immunology; Virion - metabolism; γ-Interferon
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.1601574

NK cells have been reported to respond against EBV-infected B cells in the lytic cycle and to control the viral infection involving IFN-γ secretion. Early reports proposed a role for NK cell Ab-dependent cellular cytotoxicity (ADCC) triggered via FcγR-IIIA (CD16) in the response to EBV. In the current study, we revisited this issue, showing that serum from EBV individuals triggered vigorous NK cell degranulation and cytokine production (i.e., TNF-α and IFN-γ) against EBV-infected cells, enhancing NK cell activation. The effect was preferentially directed against cells in the lytic phase and was associated with surface expression of the gp350/220 envelope Ag. In contrast, binding of gp350 particles, released by EBV-infected cells, to B cell lines or autologous primary B lymphocytes also promoted specific Ab-dependent NK cell degranulation and TNF-α production but induced minimal IFN-γ secretion. In that case, target cell damage appeared marginal compared with the effect of a control anti-CD20 Ab (rituximab) at concentrations that triggered similar NK cell activation, indicating that cell-associated gp350 particles may divert the cytolytic machinery, impairing its direct action on the plasma membrane. These observations support that Ab-dependent NK cell activation plays an important role in the control of EBV, enhancing NK cell effector functions against infected B cells in the lytic cycle. In contrast, the data reveal that gp350 particles bound to bystander B cells trigger Ab-dependent NK cell degranulation and TNF-α but not cytotoxicity or IFN-γ production, potentially favoring the progression of viral infection.